Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:30 AM
Ignite Modification Date:
2025-12-25 @ 12:30 AM
NCT ID:
NCT01794767
Eligibility Criteria:
Inclusion Criteria:
* Age between 2 years and 14 years old
* Medical prescription of intravenous antibiotic therapy for at least 2 doses on the day
* Presence of informed consent to participate to the study provided by the parents
* No known hypersensitivity to heparin
* No known hypersensitivity to the patch fixing materials (polyurethane and / or glue)
* Absence of diseases buoyancy coagulation (haemophilias and / or thrombophilias)
* No antecedents trombopenie dued to the use of any type of heparin or a pentosan polysulfate
* No existing treatment based on corticosteroids and / or anti-inflammatory
Exclusion Criteria:
* age outside the range 2 - 14 years
* children for which there is no prescription of intravenous antibiotic therapy for at least 2 times a day
* children for which the parents have not consented to the study
* children with known hypersensitivity to heparin
* children with known hypersensitivity to the patch fixing materials (polyurethane and / or adhesive)
* children with disease-causing buoyancy coagulation (Hemophilia and / or thrombophilia)
* children with antecedents of trombopenie occurring by the use of any type of heparin or of a pentosan polyphosphate
* children in treatment with corticosteroids and / or anti-inflammatory
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
14 Years
Study:
NCT01794767
Study Brief:
Protocol Section:
NCT01794767